Search

Your search keyword '"Matonti, Frédéric"' showing total 87 results
Start Over Author "Matonti, Frédéric"
87 results on '"Matonti, Frédéric"'

51. Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study

Author

Gaborit, Bénédicte, primary, Julla, Jean-Baptiste, additional, Besbes, Samaher, additional, Proust, Matthieu, additional, Vincentelli, Clara, additional, Alos, Benjamin, additional, Ancel, Patricia, additional, Alzaid, Fawaz, additional, Garcia, Rodrigue, additional, Mailly, Philippe, additional, Sabatier, Florence, additional, Righini, Maud, additional, Gascon, Pierre, additional, Matonti, Frédéric, additional, Houssays, Marie, additional, Goumidi, Louisa, additional, Vignaud, Lucile, additional, Guillonneau, Xavier, additional, Erginay, Ali, additional, Dupas, Bénédicte, additional, Marie-Louise, Jennifer, additional, Autié, Marianne, additional, Vidal-Trecan, Tiphaine, additional, Riveline, Jean-Pierre, additional, Venteclef, Nicolas, additional, Massin, Pascale, additional, Muller, Laurent, additional, Dutour, Anne, additional, Gautier, Jean-François, additional, and Germain, Stéphane, additional

Published
2019
Full Text
View/download PDF

63. Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study

Author

Gaborit, Bénédicte, Julla, Jean-Baptiste, Besbes, Samaher, Proust, Matthieu, Vincentelli, Clara, Alos, Benjamin, Ancel, Patricia, Alzaid, Fawaz, Garcia, Rodrigue, Mailly, Philippe, Sabatier, Florence, Righini, Maud, Gascon, Pierre, Matonti, Frédéric, Houssays, Marie, Goumidi, Louisa, Vignaud, Lucile, Guillonneau, Xavier, Erginay, Ali, Dupas, Bénédicte, Marie-Louise, Jennifer, Autié, Marianne, Vidal-Trecan, Tiphaine, Riveline, Jean-Pierre, Venteclef, Nicolas, Massin, Pascale, Muller, Laurent, Dutour, Anne, Gautier, Jean-François, and Germain, Stéphane

Published
2020
Full Text
View/download PDF

67. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine–Gass syndrome: the EPISODIC-2 study

Author

Bellocq, David, primary, Pierre-Kahn, Vincent, additional, Matonti, Frédéric, additional, Burillon, Carole, additional, Voirin, Nicolas, additional, Dot, Corinne, additional, Akesbi, Jad, additional, Milazzo, Solange, additional, Baillif, Stéphanie, additional, Soler, Vincent, additional, Wolff, Benjamin, additional, Scemama, Claire, additional, Malclès, Ariane, additional, Weber, Michel, additional, and Kodjikian, Laurent, additional

Published
2016
Full Text
View/download PDF

71. Correspondence

Author

Soler, Vincent J., primary, Mahieu, Laurence, additional, Matonti, Frédéric, additional, and Pagot-Mathis, Véronique, additional

Published
2015
Full Text
View/download PDF

72. Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone

Author

Hoffart, Louis, Matonti, Frédéric, Conrath, John, Daniel, Laurent, Ridings, Bernard, Masson, Guillaume, Chavane, Frédéric, Ophtalmologie [Hôpital de la Timone - APMH], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Monticelli Paradis d'Ophtalmologie, Aix-Marseille Université - Faculté de médecine (AMU MED), Aix Marseille Université (AMU), Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de neurosciences cognitives de la méditerranée - UMR 6193 (INCM), and Université de la Méditerranée - Aix-Marseille 2-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience

Published
2010

81. Rapid adaptation of fixation distribution during sentence reading with central field loss and its role in reading performance : a mediation analysis.

Author

Castet, Éric, Aguilar, Carlos, Matonti, Frédéric, and Calabrèse, Aurélie

Subjects
MEDIATION (Statistics), PERIPHERAL vision, READING speed, VISUAL fields, MEDIATION
Abstract

Age-related Macular Degeneration patients (288 million people worldwide by 2040) are blind in their central visual field and have thus great difficulty to read text. Reading with central field loss (CFL) relies on peripheral vision and requires adaptation of visuo-attentional and oculo-motor processes. It is still an open question whether reading performance depends on the systematic (or at least frequent) use of one specific portion of peripheral vision (often referred to as the Preferred Retinal Locus - PRL). To address this question, forty-four normally-sighted subjects read French sentences with a gaze-contingent artificial scotoma (a 10° disk centred on the fovea). They had to read with the "self-paced reading" technique allowing to display only one word (N) at a time while masking all other words with 'x' strings: in order to read, subjects had to unmask the adjacent word (N+1 or N-1) by using keyboard presses. Several experimental blocks were run over a period of about 2 hours. For each subject and block, a fixation heatmap was created by plotting fixation locations with respect to each word's centre. Reading speed was regressed on several characteristics of fixation maps (centroid, size, ...). Results show that reading speed correlates with the vertical coordinate of the distribution's centroid. Importantly, a statistical mediation analysis shows that improvement in reading speed between the first and the last block is partly mediated by this vertical coordinate. Consequences of these results for designing novel visual rehabilitation protocols are discussed. [ABSTRACT FROM AUTHOR]

Published
2019

82. Consensus d’experts français sur les critères de choix d’un traitement de 1eintention dans la DMLA néovasculaire et importance du ratio bénéfice/risque à long terme

Author

Couturier, Aude, Kodjikian, Laurent, Baillif, Stéphanie, Conart, Jean-Baptiste, Dot, Corinne, Delyfer, Marie-Noëlle, Matonti, Frédéric, Caillaux, Violaine, Bousquet, Elodie, Robinet, Anne, Massé, Hélène, Uzzan, Joel, Mrejen, Sarah, and Semoun, Oudy

Abstract

Le choix d’un traitement de 1èreintention pour optimiser les résultats à long terme est un enjeu majeur de la prise en charge des patients atteints de DMLA néovasculaire. Dans un contexte actuel de molécules en développement est apparue la nécessité d’identifier les critères indispensables à prendre en compte lors de la mise en place d’un traitement chez un patient naïf atteint de DMLA néovasculaire afin de garantir un rapport bénéfice/risque optimal à long terme. Cet article propose un consensus établi selon la méthodologie de type Delphi (en intégrant une gradation dans les consensus en fonction de l’analyse du taux de convergence des réponses) qui pourrait constituer une aide pour les ophtalmologistes pour l’initiation et le suivi du traitement des patients atteints de DMLA néovasculaire. Quatorze questions ont été soumises à un panel de 93 experts rétinologues français. Treize questions (93%) ont obtenu un consensus (≥ 50 % de réponses consensuelles). Les experts recommandent ainsi de prendre en compte en priorité l’efficacité et la rapidité d’action respectives des molécules, leur sécurité d’utilisation ainsi que leur capacité d’espacement des injections. Le critère d’efficacité attendu en priorité d’une molécule est la combinaison de l’amélioration de l’acuité visuelle et de l’assèchement des fluides. En matière de sécurité d’utilisation, les experts recommandent une surveillance supplémentaire pour les molécules actuellement en développement, et ce à toutes les visites programmées, visant à détecter précocement d’éventuels effets indésirables tels que l’inflammation intraoculaire et accordent une place importante au conditionnement de la molécule. La capacité d’espacement des injections est importante à prendre en compte et il est recommandé d’atteindre un intervalle maximal compris entre 12 et 16 semaines. La stabilité de l’intervalle maximal atteint par les patients est également un critère de choix important.

Published
2021
Full Text
View/download PDF

83. When love makes a lover (transiently) blind: A case report describing postcoital Valsalva retinopathy.

Author

Tolou C, Mahieu L, Hamid S, Matonti F, and Soler V

Subjects
Adult, Amaurosis Fugax physiopathology, Epiretinal Membrane etiology, Female, Humans, Pressure, Remission, Spontaneous, Retinal Hemorrhage diagnostic imaging, Retinal Hemorrhage physiopathology, Tomography, Optical Coherence, Vitreous Hemorrhage diagnostic imaging, Vitreous Hemorrhage physiopathology, Amaurosis Fugax etiology, Coitus physiology, Retinal Hemorrhage etiology, Valsalva Maneuver, Vitreous Hemorrhage etiology
Published
2017
Full Text
View/download PDF

84. [Focusing on the functional impact of retinal prothesis].

Author

Roux S, Gascon P, Pham P, Matonti F, and Chavane F

Subjects
Aged, Aged, 80 and over, Electric Stimulation, Electrodes, Implanted, Humans, Prosthesis Design standards, Recovery of Function physiology, Retinal Diseases physiopathology, Vision Disorders physiopathology, Retinal Diseases rehabilitation, Vision Disorders rehabilitation, Vision, Ocular physiology, Visual Prosthesis standards
Published
2017
Full Text
View/download PDF

86. [Dislocation in anterior chamber of dexamethasone intravitreal device].

Author

Cousin M, Hoffart L, Baeteman C, and Matonti F

Subjects
Drug Implants, Eye Foreign Bodies therapy, Foreign-Body Migration therapy, Head-Down Tilt, Humans, Intraocular Pressure physiology, Macular Edema etiology, Male, Middle Aged, Postoperative Complications, Pseudophakia etiology, Visual Acuity physiology, Vitrectomy, Vitreous Body, Anterior Chamber pathology, Dexamethasone administration & dosage, Eye Foreign Bodies etiology, Foreign-Body Migration etiology, Glucocorticoids administration & dosage, Macular Edema drug therapy
Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results